This is a ready-to-use qualification protocol for a gaseous bio-decontamination cycle, most commonly vaporized hydrogen peroxide (VHP), in an isolator or restricted access barrier system (RABS). This is a decontamination-efficacy study layered on top of an isolator or RABS enclosure that is already HVAC-qualified for HEPA integrity, particle class, and pressure; it does not repeat or replace that qualification, and it is not replaced by it. Replace every <<FILL: ...>> placeholder, and confirm each cited standard against the current source before you rely on it. A filled specimen follows.
Approval page
| Role | Name | Signature | Date |
|---|---|---|---|
| Author (Validation / C&Q) | <<FILL>> | ||
| Reviewer (Engineering / SME) | <<FILL>> | ||
| Reviewer (Microbiology) | <<FILL>> | ||
| Approver (Quality Assurance) | <<FILL>> |
| Field | Entry |
|---|---|
| Protocol number | <<FILL: e.g. QUAL-DEC-001>> |
| Version | <<FILL>> |
| Isolator / RABS ID | <<FILL>> |
| Decontamination agent | <<FILL: e.g. vaporized hydrogen peroxide, chlorine dioxide>> |
1. Objective
Demonstrate through documented cycle development, biological indicator kill testing, distribution mapping, and residual verification that the bio-decontamination cycle achieves a defined and reproducible kill of a resistant biological challenge throughout the isolator or RABS interior, including worst-case and shadowed locations, and clears to a safe residual level before product or operator re-entry.
2. Scope
Covers the bio-decontamination cycle for <<FILL: isolator / RABS ID>> as installed and HVAC-qualified under <<FILL: HVAC qualification protocol ID>> (see Clean Utilities Qualification). This protocol does not qualify HEPA integrity, particle classification, or pressure cascade; those are addressed separately. It covers the decontamination cycle only, for the aseptic operation described in <<FILL: reference the aseptic process, see Aseptic Processing and Media Fills>>.
3. System description
<<FILL: describe the isolator or RABS design, chamber volume, generator/injection point location, aeration/exhaust path, glove ports and sleeves, equipment and fixtures present during the cycle, and the decontamination agent and delivery system.>>
4. Prerequisites
- The isolator or RABS HVAC qualification (HEPA integrity, particle class, pressure cascade) is complete and current; see Clean Utilities Qualification.
- Biological indicators selected and qualified per the current edition of PDA Technical Report No. 51 (Biological Indicators for Gas and Vapor-Phase Decontamination Processes); carriers are inoculated with a defined population of a resistant organism, commonly Geobacillus stearothermophilus spores.
- Chemical indicators or a validated residual-agent sensor are available and calibrated.
- Equipment and fixture layout for the cycle is defined and representative of routine use.
5. Acceptance criteria (cycle level)
The cycle is qualified when cycle development establishes a reproducible exposure with a documented margin, every biological indicator placed per the distribution map (including worst-case and shadowed locations) shows the defined kill result, residual agent clears to the defined limit before the re-entry hold time ends, and all deviations are closed.
6. Cycle development
| ID | Activity | Expected result | Actual | Pass/Fail |
|---|---|---|---|---|
| CD-01 | Define exposure parameters (concentration, dwell time, aeration time) | Parameters established per the development study, generally per the current edition of ISO 22441 applied by analogy | <<FILL>> | <<FILL>> |
| CD-02 | Establish cycle margin (e.g. a fractional or half-cycle approach) | A defined, documented margin over the minimum effective exposure | <<FILL>> | <<FILL>> |
| CD-03 | Define the re-entry residual limit and hold time | Limit and hold time defined and justified | <<FILL>> | <<FILL>> |
7. Distribution mapping and biological indicator test cases
List every biological indicator location in Attachment A, including the worst-case / shadowed locations (behind equipment, inside glove sleeves, corners, seams, areas distal from the injection point).
| ID | Location | Rationale | Result | Pass/Fail |
|---|---|---|---|---|
| BI-01 | <<FILL: e.g. near injection point>> | Reference / easiest-access location | <<FILL>> | <<FILL>> |
| BI-02 | <<FILL: e.g. behind largest equipment item>> | Shadowed from direct vapor path | <<FILL>> | <<FILL>> |
| BI-03 | <<FILL: e.g. inside glove sleeve, fingertip>> | Confined, low-exchange location | <<FILL>> | <<FILL>> |
| BI-04 | <<FILL: e.g. farthest corner from injection point>> | Distal, lowest expected exposure | <<FILL>> | <<FILL>> |
| BI-05 | <<FILL: additional site-specific worst case>> | <<FILL>> | <<FILL>> | <<FILL>> |
All biological indicators placed per Attachment A must show the defined kill result (commonly complete inactivation with no growth on recovery) for the cycle to pass. A single positive (growth) result at any location fails the cycle and requires investigation before repeat testing.
8. Residual verification
| ID | Verification | Expected result | Actual | Pass/Fail |
|---|---|---|---|---|
| RV-01 | Residual agent level at end of aeration, worst-case location | Within the defined re-entry limit | <<FILL>> | <<FILL>> |
| RV-02 | Residual agent level at the product-contact surface closest to the injection point | Within the defined re-entry limit | <<FILL>> | <<FILL>> |
| RV-03 | Confirm aeration hold time is sufficient across three consecutive cycles | Consistent clearance within the hold time on all three runs | <<FILL>> | <<FILL>> |
9. Deviation handling
Record each discrepancy, including any single biological indicator positive, as a numbered deviation, assess impact, determine root cause (commonly a mapping gap or an equipment/layout change that created a new shadowed area), resolve, and re-test. QA approves each deviation and the final disposition.
10. Summary and conclusion
| Field | Entry |
|---|---|
| Cycle development result | <<FILL>> |
| Biological indicator result (all locations) | <<FILL>> |
| Residual verification result | <<FILL>> |
| Deviations raised / closed | <<FILL>> |
| Conclusion | <<FILL: cycle qualified / not qualified>> |
| Approved by (QA) | <<FILL: name, signature, date>> |
11. Attachments
Attachment A: biological and chemical indicator location map (diagram). Attachment B: calibration certificates. Attachment C: raw data and biological indicator recovery records.
12. References
ISO 22441, Sterilization of health care products, low temperature vaporized hydrogen peroxide, requirements for development, validation and routine control (written for medical devices; applied by analogy to isolator/RABS bio-decontamination). PDA Technical Report No. 51, Biological Indicators for Gas and Vapor-Phase Decontamination Processes. ISO 11138-1, general requirements for biological indicators. EU GMP Annex 1 (2022). Related reading: Clean Utilities Qualification, Aseptic Processing and Media Fills, Disinfectant and Sporicidal Efficacy Qualification.
Confirm the current version of each reference before issue.
13. Revision history
| Version | Date | Author | Summary of change |
|---|---|---|---|
<<FILL: 1.0>> | <<FILL>> | <<FILL>> | Initial issue. |
Filled specimen
The following shows a completed distribution-mapping summary for an example isolator bio-decontamination cycle, so you can see how a passing and a once-failing cycle read. The values are illustrative.
| Location | Rationale | Result |
|---|---|---|
| Near injection point | Reference location | Complete kill, no growth |
| Behind the filling needle assembly | Shadowed from direct vapor path | Complete kill, no growth |
| Glove sleeve fingertip, left glove | Confined, low-exchange location | Growth observed on first run; cycle failed |
| Farthest corner from injection point | Distal, lowest expected exposure | Complete kill, no growth |
In this example the first cycle run failed at the glove sleeve fingertip, a location with little direct vapor exchange. The investigation found the glove was not fully inflated during the cycle, reducing vapor contact at the fingertip; the glove-inflation step was added to the cycle’s standard setup, and the repeat run passed at all four locations, including the previously failing one. That finding, investigate, correct, re-test sequence at the actual worst-case location is what a cycle qualification is supposed to produce.
Common inspection findings this protocol prevents
- Biological indicators placed only near the injection point or the sensor, where the cycle is guaranteed to pass, with no genuine worst-case or shadowed-location challenge.
- No residual agent verification before re-entry, or a fixed aeration time applied regardless of load or layout.
- A cycle qualification treated as permanent, with no reverification after an equipment, glove, or layout change.
- Cycle qualification confused with, or substituted for, the isolator’s HEPA integrity, particle classification, or pressure cascade qualification.
How to adapt this protocol
- Set your protocol number, isolator/RABS ID, and decontamination agent on the approval page.
- Build the real distribution map in Attachment A from your own equipment layout, including every shadowed and confined location you can find, not just the convenient ones.
- Set your cycle parameters, margin, and residual limit from your own development study; do not carry a number from another site’s cycle.
- Confirm the HVAC qualification referenced in section 4 is complete and current before starting this protocol.
- Confirm every standard in section 12 against the current published version before issue.